2026 Annual Meeting | C180 - Update on the Immunotherapies of Myasthenia Gravis
| 11:15 AM - 11:16 AM CDT | Introduction |
Introduction
Yuebing Li, MD, PhD, FAAN |
| 11:17 AM - 11:43 AM CDT | Speaker |
Reviewing of Traditional Immunotherapies for Myasthenia Gravis
John A. Morren, MD, FAAN |
| 11:44 AM - 12:10 PM CDT | Speaker |
Reviewing of Newer-generation Immunotherapies for Myasthenia Gravis
Yuebing Li, MD, PhD, FAAN |
| 12:10 PM - 01:10 PM CDT | Q&A |
Questions and Answers
Yuebing Li, MD, PhD, FAAN, John A. Morren, MD, FAAN |
| Yuebing Li, MD, PhD, FAAN | Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx. |
| John A. Morren, MD, FAAN | Dr. Morren has received publishing royalties from a publication relating to health care. |